In order to address a more precise estimation of this relationship, a meta-analysis including a total of 18 studies was performed, which may provide the more comprehensive evidence for the association of XRCC1 Arg399Gln variants with HNSCC risk. Here, XRCC1 is linked to head and neck squamous cell carcinoma.